drax exametazime
Generic: kit for the preparation of technetium tc 99m exametazime for leukocyte labeling
Labeler: jubilant draximage inc., dba jubilant radiopharmaDrug Facts
Product Profile
Brand Name
drax exametazime
Generic Name
kit for the preparation of technetium tc 99m exametazime for leukocyte labeling
Labeler
jubilant draximage inc., dba jubilant radiopharma
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
technetium tc-99m exametazime .5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
65174-200
Product ID
65174-200_9799f139-0c16-4cf0-8a7d-e9668ec3f146
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA208870
Listing Expiration
2026-12-31
Marketing Start
2017-08-17
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65174200
Hyphenated Format
65174-200
Supplemental Identifiers
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
drax exametazime (source: ndc)
Generic Name
kit for the preparation of technetium tc 99m exametazime for leukocyte labeling (source: ndc)
Application Number
NDA208870 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .5 mg/1
Packaging
- 5 VIAL in 1 CARTON (65174-200-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (65174-200-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "9799f139-0c16-4cf0-8a7d-e9668ec3f146", "openfda": {"nui": ["N0000177914", "N0000000205"], "unii": ["3B744AG22N"], "spl_set_id": ["fa7811f9-2803-4126-8037-8f3e56462f9c"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "manufacturer_name": ["Jubilant DraxImage Inc., dba Jubilant Radiopharma"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL in 1 CARTON (65174-200-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (65174-200-01)", "package_ndc": "65174-200-05", "marketing_start_date": "20170817"}], "brand_name": "Drax Exametazime", "product_id": "65174-200_9799f139-0c16-4cf0-8a7d-e9668ec3f146", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Radioactive Diagnostic Agent [EPC]", "Radiopharmaceutical Activity [MoA]"], "product_ndc": "65174-200", "generic_name": "Kit for the Preparation of Technetium Tc 99m Exametazime for Leukocyte Labeling", "labeler_name": "Jubilant DraxImage Inc., dba Jubilant Radiopharma", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Drax Exametazime", "active_ingredients": [{"name": "TECHNETIUM TC-99M EXAMETAZIME", "strength": ".5 mg/1"}], "application_number": "NDA208870", "marketing_category": "NDA", "marketing_start_date": "20170817", "listing_expiration_date": "20261231"}